Ascentage (AAPG) news
Recent news
Ascentage Pharma Group International: Citigroup initiates coverage with buy rating; target price $46
Citigroup has initiated coverage of Ascentage Pharma Group International with a "Buy" rating and a target price of $46 per share, reflecting the firm's positive outlook on the company's growth prospects and therapeutic pipeline [1]. The investment bank highlighted the company's focus on innovative…
AInvest Wire · 1d agoAscentage Pharma Group International - Chairman buys 38,630 shares for HK$1.2 mln at HK$29.95 per share on Sept 23-25
Ascentage Pharma Group International's chairman has acquired 38,630 shares in the company for HK$1.2 million at an average price of HK$29.95 per share between September 23 and 25, 2026. The purchase reflects a significant personal investment in the company's stock, which may be interpreted as a…
AInvest Wire · Sep 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.